免疫チェックポイント阻害薬関連肝毒性のために肝生検を受けた患者における臨床および組織病理学的特徴のスペクトル：10年間の多施設経験

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials· 2023 · 95 citations
2. PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease· 2024 · 14 citations
3. Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data· 2023 · 24 citations
4. Histopathology of Gastrointestinal Immune-related Adverse Events· 2021 · 24 citations
5. Pathologic Manifestations of Gastrointestinal and Hepatobiliary Injury in Immune Checkpoint Inhibitor Therapy· 2020 · 59 citations